📰 Temporary Authorization News
Temporary Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Temporary Authorization. Real-time updates on events, politics, business and more.
November 21, 2023
ABIONYX Pharma announced new positive results in ophthalmology for the first class of CER-001-based biomedicines for the treatment of ocular pathologies, and the appointment of Mr. Jérôme Martinez...
January 16, 2023
Positive results on primary and secondary endpoints, identifying dose for future development Direct and significant effect of CER-001 on endotoxin removal and consequent reduction in the inflammatory
December 21, 2022
SpaceX may begin deploying second-gen Starlink satellites this month, according to regulatory filings.
October 28, 2022
EMA D120 Responses submitted in October as planned Two successful engineering batches of LUMEVOQ validate actions taken to correct low yields in previous runs €13.9 million of cash
July 28, 2022
Ramp up of sales marketing actions and investments to drive commercial launch of LUMEVOQ in Europe in 2023 Cash runway confirmed to early Q1 2023 Advanced discussions on refinancing
April 21, 2022
Sustained demand of LUMEVOQ ATUs in France generating €3.1 million revenues in Q1 2022 €36.0 million of cash as of March 31, 2022; runway confirmed to early Q1 2023 Regulatory News: GenSight
April 14, 2022
As of December 31, 2021, cash and cash equivalents were €43.3 million and turnover was €1.0 million Success of Euronext Paris IPO in November 2021 with €35.7 million capital raised, after
July 29, 2021
GenSight Biologics Reports Interim Financial Results for the First Half of 2021 and Provides Operational Update ATUs in France in Europe in H1 2022 Successful refinancing in Q1 2021 secures mid-2023 runway Multiple regulatory and clinical milestones expected in Q4 2021 Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cen...
May 13, 2021
Scottsboro is stated to operate a secondary aluminum processing facility (“Facility”) in Jackson County, Alabama. The Facility includes an aluminum scrap dryer operated pursuant to the authority of Air Permit No. 705-0030-X006 (“Permit”). Emissions from the aluminum scrap dryer are stated to be controlled by a baghouse. ADEM is stated to have conducted an inspection of the Facility on September 29, 2020. The CO provides that Scottsboro was operating the aluminum scrap dryer without its ...
April 28, 2021
Advicenne Reports its Full-Year Financial Results to December 31, 2020 and Confirms its 2021 Outlook Regulatory News: Advicenne (Paris:ADVIC) (BSE:ADVIC) (Euronext: ADVIC), a French company specialized in the development of therapeutic products adapted to children and adults for treating nephrological and neurological orphan diseases, today reported its 2020 financial results. 2020 HIGHLIGHTS Scientific developments On March 10, 2020, Advicenne was authorized to make ADV7103 available within t...